Notice2021-14686
Solicitation of Nominations for Appointment to the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 12, 2021
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC) is seeking nominations for membership on the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT). The CHACHSPT consists of 18 experts in fields associated with public health; epidemiology; laboratory practice; immunology; infectious diseases; drug abuse; behavioral science; health education; healthcare delivery; state health programs; clinical care; preventive health; medical education; health services and clinical research; and healthcare financing, who are selected by the Secretary of the U.S. Department of Health and Human Services (HHS).
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 130 (Monday, July 12, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 130 (Monday, July 12, 2021)]
[Notices]
[Pages 36549-36550]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-14686]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the CDC/HRSA
Advisory Committee on HIV, Viral Hepatitis and STD Prevention and
Treatment (CHACHSPT)
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
seeking nominations for membership on the CDC/HRSA Advisory Committee
on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT).
The CHACHSPT consists of 18 experts in fields associated with public
health; epidemiology; laboratory practice; immunology; infectious
diseases; drug abuse; behavioral science; health education; healthcare
delivery; state health programs; clinical care; preventive health;
medical education; health services and clinical research; and
healthcare financing, who are selected by the Secretary of the U.S.
Department of Health and Human Services (HHS).
DATES: Nominations for membership on the CHACHSPT must be received no
later than August 31, 2021. Packages received after this time will not
be considered for the current membership cycle.
ADDRESSES: All nominations should be electronically mailed to
<a href="/cdn-cgi/l/email-protection#80eee3e8e8f3f4f0f0efece9e3f9c0e3e4e3aee7eff6"><span class="__cf_email__" data-cfemail="a9c7cac1c1daddd9d9c6c5c0cad0e9cacdca87cec6df">[email protected]</span></a>.
FOR FURTHER INFORMATION CONTACT: Staci Morris, M.S., Committee
Management Specialist, National Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention, CDC, Atlanta, Georgia 30329-4027; Telephone:
(404) 718-7479; <a href="/cdn-cgi/l/email-protection#5b35383333282f2b2b34373238221b383f38753c342d"><span class="__cf_email__" data-cfemail="9ef0fdf6f6edeaeeeef1f2f7fde7defdfafdb0f9f1e8">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The Secretary of HHS, and by delegation, the
CDC Director and the HRSA Administrator, are authorized by the PHS Act
to: (1) Conduct, encourage, cooperate with, and assist other
appropriate public health authorities, scientific institutions, and
scientists in the conduct of research, investigations, experiments,
demonstrations, and studies related to the cases, diagnosis, treatment,
control, and prevention of physical and mental diseases, and other
impairments; (2) assist states and their political subdivisions in
preventing, suppressing, and treating communicable diseases and other
preventable conditions and in promoting health and well-being; (3)
assist public and non-profit private entities in preventing,
controlling and treating sexually transmitted diseases (STDs),
including the Human Immunodeficiency Virus (HIV); (4) improve health
and achieve health equity through access to quality services and a
skilled health workforce and innovative programs; (5) support
healthcare services to persons living with or at risk for HIV, viral
hepatitis,
[[Page 36550]]
and other STDs; and (6) advance the education of health professionals
and the public from HIV, viral hepatitis, and other STDs.
The CDC/HRSA Advisory Committee on HIV and STD Prevention and
Treatment meets at least two times each calendar year, or at the
discretion of the Designated Federal Officer in consultation with the
CHACHSPT co-chairs.
The CDC/HRSA Advisory Committee on HIV and STD Prevention and
Treatment shall advise the Director, CDC, and the Administrator, HRSA,
regarding objectives, strategies, policies, and priorities for HIV,
viral hepatitis, and other STD prevention and treatment efforts,
including surveillance of HIV infection, Acquired Immunodeficiency
Syndrome (AIDS), viral hepatitis, other STDs, and related behaviors;
epidemiologic, behavioral, health services, and laboratory research on
HIV, viral hepatitis, and other STDs; identification of policy issues
related to HIV/viral hepatitis/STD professional education, patient
healthcare delivery, and prevention services; agency policies about
prevention of HIV, viral hepatitis and other STDs, treatment,
healthcare delivery, and research and training; strategic issues
influencing the ability of CDC and HRSA to fulfill their missions of
providing prevention and treatment services; programmatic efforts to
prevent and treat HIV, viral hepatitis, and other STDs; and support to
the agencies in their development of responses to emerging health needs
related to HIV, viral hepatitis and other STDs.
Nominations are being sought for individuals who have expertise and
qualifications necessary to contribute to the accomplishments of the
committee's objectives. Nominees will be selected based on expertise in
the fields of public health; epidemiology; laboratory practice;
immunology; infectious diseases; drug abuse; behavioral science; health
education; healthcare delivery; state health programs; clinical care;
preventive health; medical education; health services and clinical
research; and healthcare financing. The Committee shall also include
representation of persons with HIV and other affected populations;
state and local health and education agencies; HIV/viral hepatitis/STD
community-based organizations; and the ethics or faith-based community.
Federal employees will not be considered for membership. Members may be
invited to serve for up to four-year terms.
Selection of members is based on candidates' qualifications to
contribute to the accomplishment of CHACHSPT objectives. The U.S.
Department of Health and Human Services policy stipulates that
committee membership be balanced in terms of points of view
represented, and the committee's function. Appointments shall be made
without discrimination on the basis of age, race, ethnicity, gender,
sexual orientation, gender identity, HIV status, disability, and
cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens, and cannot be full-time employees of the U.S. Government.
Current participation on federal workgroups or prior experience serving
on a federal advisory committee does not disqualify a candidate;
however, HHS policy is to avoid excessive individual service on
advisory committees and multiple committee memberships. Committee
members are Special Government Employees (SGEs), requiring the filing
of financial disclosure reports at the beginning and annually during
their terms. Individuals who are selected for appointment will be
required to provide detailed information regarding their financial
interests and, for example, any work they do for the federal government
through research grants or contracts. Disclosure of this information is
required in order for CDC ethics officials to determine whether there
is a conflict between the SGE's public duties as members of CHACHSPT
and their private interests, including an appearance of a loss of
impartiality as defined by federal laws and regulations, and to
identify any required remedial action needed to address the potential
conflict. CDC reviews potential candidates for CHACHSPT membership when
a vacancy arises and provides a slate of nominees for consideration to
the Secretary of HHS for final selection. HHS notifies selected
candidates of their appointment near the start of the term in December
1, 2021, or as soon as the HHS selection process has been completed.
Note that the need for different expertise varies from year to year and
a candidate who is not selected for an open position may be
reconsidered for a subsequent open position. SGE nominees must be U.S.
citizens, and cannot be full-time employees of the U.S. Government.
Candidates should submit the following items:
[ssquf] Current curriculum vitae or resume, including complete
contact information (telephone numbers, mailing address, email
address).
[ssquf] At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
(Candidates may submit letters(s) from current HHS employees if
they wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
[ssquf] A biographical sketch of the nominee (500 words or fewer).
[ssquf] A letter of interest or personal statement from the nominee
stating how their expertise would inform the work of CHACHSPT.
Nominations may be submitted directly by the individual seeking
nomination or by the person/organization recommending the candidate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-14686 Filed 7-9-21; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on July 12, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.